Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
rose@ It is a depressing story being in AMRN right now - no way around it.
Ever falling for almost 2 years (short break before appeal - only).
----------------
And next - where to go with this?
JT did not want or anticipate this - nor did BOD or rest of Amarin management of staff.
So everything always comes back to Disaster Ruling - Disaster Ruling - that absolutely killed every bit of optimism in the AMRN stock.
And as said a million times here' - to give this kind of Power to a local 'not science educated Judge' - being able to Move +6 billion in the market - and at the same time - in this one Wrong Move (based on Hikma Freud) 'kill a small company' that has used more than 25 years to 'Get There' !
It is just so Damn Unfair - that it hurts for everyone' having to experience this - knowing 'that where we are' chances of 'restoring of the patents ever' - is close to none existing at this point.
This little Nevada Judge Ruined Thousand of honest investors in the market that day in Marts. And surely everyone at Amarin - suffers with the rest of us - over that - every day.
rose@ You wander if that (using hopping on Water) was actually deliberate.
But a wild shot it was (and prob. not JL - or we would have heard) :)
Gus@ Hopefully he's in good health - playing golf somewhere - trying to forget AMRN downfall :)
Dont know if you want to Cry' of Laugh' of the Success record of this Guy.
https://www.tipranks.com/analysts/leland-gershell
But Sadly - he did actually foresee the Downfall of Ammarin with the $7 take when every other Analyst was above $30.
He obviously enjoys putting salt in the Amarin downfall wound - as with article today:
https://finance.yahoo.com/news/good-entry-point-amarin-stock-235817330.html
Cardio@ Found in History - Thanks again :)
http://talksense.dk/what-is-the-hammer-what-is-the-scorecard.html
sts@ I actually talked to my old friend yesterday for an hour (we vent to school together in the Middle Ages many years agó) - but have had contact ever since).
-------------------
And this Covid business does become more an more 'one big line of unanswered questions'. He did actually 'get Covid himself - from the Mink.
He is 68 years old. Went to bed with flu-like symtoms for a day - and it was over - he was fine again (no treatment of any kind).
But the animals were sick he told me - no doubt about it. A number died (few which is not uncommon in this line of production). But 5- 6 days everything back to normal on the farm.
--------------------
But then they got the message from authorities - that a new strain had been found from virus experts - and test showed that the new mutated virus 'did not respond to samples of the Vaccines on the way - and that is what Rang the Big Alarm Bell. So now 'besides all Mink being destroyed and burned' - a number of counties is completely 'locked down for the next month' trying to 'stop' the Mutated Covid strain from spreading.
------------------
Only problem is that 'already this evening we head that also Swedish Mink areas are now infected with Covid (and in Denmark there is a big number of workers from Letland and Lithaun working on the Mink Farms (Eastern Europe) whom many have gone back to their home country - possible carrying the New Virus - so chances are' - that using tens of billions to 'Kill the complete Mink (Fur) business in Denmark is a complete waste of money and effort - the New Virus has already left our little country (and it might actually just behave like a normal flue - nobody investigated that)
Our planet is very much 'out of order' for the moment.
Capt@ This is potential Dynamit. Here is something 'with meat on' - to Amarins Law guys and - the bright guys of The Board to Go After :)
Thanks for sharing.
louie@ Not a nice time 'anywhere' actually - and surely not in USA either.
Our Investment is at 'Rock Bottom' - election is a Mess - hope your big country lands of It's Feets - at some point.
sts@ It is getting Ugly - for all the talk and plans from JT and management - market just doesn't buy it.
----------------------
Same people in management (not even Kennedy (9th circuit) fired).
Same continued stories of Form 4's (cash cow) - actually not ONE BIT of REAL news in yesterdays 3. Q report.
Same story of GIA Europe - again not One Bit of REAL NEWS - to please WS.
-------------------------
Only REAL news of the day was - Hikma Launce of Generic ("just happened to be released same day as Amarin 3. Q report").
----------------------
Answer to the 'Nothing Burger' from Amarin (talking REAL news) - WS and the market gave today - bringing the SP to lowest since before R-I 2018.
sts@ T
Lrich@ I do respect your insight here - and arguments (smart management could have done a lot better) !
-----------------
I remember most of your points - and we actually don't disagree that much - I sure would have wished JT and BOD have done better.
I did made a post at a point 'arguing' that there was newer a 'way out' for investors after the +$20 period late 2019 - the SP simply 'slide' back continuously from there - in fact all the way until today (exception +$7 before appeal - but not really a way out - even one of my sons left at that point - good for him today).
-----------------
As I said 'I do understand your points' for sure. So it in the end more 'don't waist your time over spilled milk' way of thinking I admit.
We have to look forward like it or not (there's no going back). And how I read it JT is not going anywhere 'by himself' (or by way of BOD) - so we might as well get used to it - and try to influence the direction of company with that 'as a Given'.
Its simply a waist of time and energy - to keep looking/digging in faults of the past. Goes for every investing strategy - and also for this - until now for me 'disaster of an investment' - measuring it today' :)
Atb
Jasbg
Lrich@ It's been 7 months - since Marts 30 2020 ruling. Before that everything was Sunshine :)
---------------------------
If you think this is hard I have a near friend who has to (in the next 5 days) kill 4.000 Mink (that has developed a different strain of Covid-19 (so the health authorities says). We are talking 7- 8 cases of Covid-19 (no one died) 'but experts "think" it is a new strain.
---------------------------
This resulting in 'that a complete profession - that has developed over 80- 100 years - with thousand of Employee's - is laid dead (in a few days) 17.000.000 Mink has to be destroyed (costing billions in loss for the farmers) that is partly compensated. All connected industries 'dead over night'.
---------------------------
Compared to this - a tragedy for people involved (grown men crying on Television have been shown all day in our small country) - problems for AMRN investors' - with 'an investment gone bad' (hopefully temporarily) - does seem something to overcome :)
Lrich@ It's been 7 months - since Marts 30 2020 ruling. Before that everything was Sunshine :)
Downtown@ It was actually Kiwi blocking me' - for the record !
But seems he might get his Sleepy friend in office (God help Us all) :)
Link to todays Podcast (if already brought here no harm done):
https://www.webcaster4.com/Webcast/ListenPage?companyId=2037&webcastId=38230
Lrich@ I'm trying - deliberately - to be positive in evaluating movements of JT and Amarin.
--------------
But at the same time I do see your points for sure - and do want to Screem - at a development of SP like today (what happens every time there in 'Information's from Amarin).
---------------
And Hikma announce - "by coincidence announce launching" - the day of Amarins Q3 - not a chance - they quite obviously enjoy this !
Lrich@ The strategy is - GIA in Europe. Me and many others have been against that' - But that IS THE STRATEGY.
-----------------------------------------
3- 5 years from now - future might show 'It was the right Strategy' - also for Shareholders - only time can tell.
JT is the biggest shareholder of all (private persons) - and you can read development backswords - 'he must feel and want to Prove' that this company has the potential to 'bee BIG' - make Shareholders Real Money - or he would have thrown in the towel - already - given the massive critic he's had to endure since loss in patent trial - some 7 months ago (feels like years - right) :)
----------------------
I suppose going after/slowing down Generic's every way possible (for infringement - whatever) is part of keeping US Branded market alive - long as possible.
Jasbg
Downtown - Lrich@ The short answer is. Downfall of Amarin is 99% related to Nevada Ruling Marts 30. Had that been a Win SP today would have been $35- 50.
Company did everything possible 'to repair' on the disaster ruling (hiring Singer etc.) - but everything failed up until now 'in restoring the 6 destroyed Patens' - this is 'todays reality'
----------------------
We all have a lot of plans for life' - if you suddenly get cancer (or even worse - your child gets cancer) everything chances - you have to adapt to this completely unexpected situation.
This is where Amarin are 'as a company right now - 'hit by a very bad generic cancer' - where to go from here ?
---------------------
And giving it some thought - I can accept what JT and Amarin is doing (would have preferred a $20- 25 BO tomorrow) - but given 'that is not going to happen' - I'm reasonable pleased with 3rd Quarter Report - and prospects of the future.
Jasbg
Downtown@ Your right - the worst is often the uncertainty - also for investors.
I actually liked 85% of the report from JT and Amarin today.
The money situation looks very good for the company - IMPORTANT always.
Company have decided to 'ignore' generic start in US - and keep strategy for promoting Vascepa - full speed - course this is were the company 'makes money' right now. The rezoning does make sense.
GIA in Europe is HOW IT'SGOING TO BEE - end of story.
All in all a sensible report from Amarin - and I think when It sinks in - we will actually see the SP rise over the next month - nice and easy - could turn higher at the end already today.
Certainty is better - than the ever guessing.
Jasbg
cbb@ I think we just might as well 'Drop spending time the arguments On BO - for now (I have supported your views - when I were depressed about development - a number of times - latest here today).
--------------------
As I stated elsewhere a couple of days ago: "BO is simply not going to happen" - and today's statement from JT - also 'Once and for All for now - makes it clear GIA in Europe - is HOW IT'S GOING TO BEE - so fighting against it - is simply waist of time and energy for everybody - end of story.
JT from today on Europe:
“We are excited to be nearing the EMA’s regulatory decision on VASCEPA and are busy preparing for our anticipated commercial launch in Europe, where there is a large and growing opportunity for Amarin to bring this proven effective therapy to the millions of patients at high risk for cardiovascular events. Launching on our own in major markets in Europe allows us to create the greatest value as Amarin would not have to share profits with a partner. Importantly, we can leverage the knowledge and experience gained from the tremendous progress made by our U.S. commercial team.
mrmain@ INVESTOR RELATIONS / AMARIN REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
https://investor.amarincorp.com/news-releases/news-release-details/amarin-reports-third-quarter-2020-financial-results-and-provides
I haven't found a link to 'Broadcast version' - but text says there should be one shortly.
Anyone has a link to discussion from earlier today ?
isaeed@ You read my post 'completely wrong' if you saw it as optimistic.
We are at a Absolut 'LOW Point' for Amarin. In 2019 they finally Got There' - and then throw's it all away - less than 4 months later (because of Kennedys comfort - shorter travel to 9th Circuit).
---------------------
You read the post's wrong. What we are saying is that Jt and BOD - 'have to move aside' - they have lost 100% - and needs to 'hand over/sell' to BP who has the power to move Vascepa to the market rest off the World - fast as possible.
As cbb has said over and over - Only BP can do that - Amarin is 'Stock' - has run out of options. But Of Course Vascepa still holds some value for EU and China - but for how long ?
US Is Lost for Amarin - BP might be able to 'save some of the pieces - going AG - at a point when Brand version dies.
cbb@ I think we are at a point where a BP Buy Out - is not only 'our best hope'. After Hikma now has announced its Launce of GV in USA - IT IS more like OUR ONLY HOPE.
GIA in Europe will simply drain the Company for money (Europe is a jungle of different languages and regulations - even more so than US).
Only problem is - that Amarin seem more focused on passing Form 4's than taking the 'Right forward looking decisions' for the future of the Company and shareholders.
But as things look now' for US Market - JT and management must realize 'that the ship for branded success of Vascepa in USA - is Sailing - something has to happen - and 'happen soon'
And as you have pointed out again' - and again' - the only Real Solution - is to Sell the Company NOW to BP. It should have been done long ago - but 'crying over spilled milk' - is a waste of time.
Time for JT and management to show 'what they are made off'.
BB@ We are already in the water - have missed two Lifeboats - and are sinking (Hikma Launch) - and you are talking about the 'Next Law Cruise'
Have to admire your spirit/optimism for sure :)
sts@ The biggest mistake 'JT makes in his life' - to accept 9th Circuit.
Amarin has newer given an explanation Why' - so the common guess that it was all about the comfort of Kennedy stands - until someone from Amarin explains otherwise.
A total Disaster for this Company that cost shareholders +6 billion dollars - SP down to $4 after Marts ruling - would have gone 'easy' to $20 on a WIN (400 mill shares x 16= 6.4 billion)
Actually - Summing Up the Law Process that killed Amarin (moved +6 billion dollar in the market - Marts 30 ruling).
Looking back at events - think this io-io poster (likely a Judge) might have been right all along.
What he was saying was - that the number of 'direct contacts of Law people' to Judge Du of Nevada (he called it 'Vicious Attacks' on the Judge) would in itself' ensure 'No Chance at Appeal' - there by implying that 'Just like that Military people at war 'will always 'stand by' their own - as far as possible - the same solidarity exist between Judges.
Winning appeal - would not have been likely anyway - but the way that Dyke - just through Amarin (and Singer) under the buss - company newer stood a chance. And given that Judges (and the Courts are Immune / cant be touched) - this is a God-Like institution - where common sense and arguments - after a ruling is 100% without influence - which the SP tells us every day.
-------------------
All the great efforts of iHub Board - the best most pro. people working to make the Amicus Brief - and these CAFC Gods (on their high horses) just send a message 'DENIED' !
And a few weeks later the complete En Banc 'DENIED' - it does make you - as a normally Law Abiding Citizen - want to CALL THE GODS - to send Lighting's on this institution - to Make them understand how misuse of power (and the arrogance) of their Closed Brotherhood seemingly not caring about 'real' justice at all' - feels to ordinary men and woman being affected by their Rulings.
Jasbg
That this is a rotten Year - and even more for AMRN shareholders - has just 'Again - Again - been proved.
----------------------
En banc - is a general Joke in Law - giving the losers the impression - they still have a chance - a Joke simply. And CAFC wait 'weeks to' announce deneil - just to 'further damage Amarin'.
Looking from abroad US Justice system is - a deeply political infiltrated - Lobby controlled (meaning money controlled) - layer of power - that is destroying 'real progress' in so many ways in America.
All in all a very sad and depressing experience - for thousands of serious investors in the market (some who has been completely ruined - by the little lady Judge in Nevada).
-----------------------------
Amarin is a 'one drug' company that has been through a 'marathon process of getting their product acknowledged' - and when they (after 25 years of research) - are Finally There - this 'little 'non science educated' Judge (fooled by 'direct freud' evidence presented by pro' bloodhound Lawyers from Hikma) - in a moment destroyed decades of hard work of a small company - in one blindfolded deeply political ruling.
And to put 'salt in the wounds' of suffering Amarin investors - I see now again a lot of talk about Form 4 - bonuses at Amarin. I sure hope this is not a repetition of last time (pis**** on shareholders) - If so this company is on the way down the tubes - and rightfully so.
Jasbg
Mateo@ Good that you haven't given up on your problem.
Just to follow up on my own filosofi of getting through life 'in a good way'.
I'm absolutely Not a believer in drugs generally. All my life (close to seventy - months) I have only been taking vitamins to 'keep a decent health'.
Have avoided any 'permanent medicine' if possible' - Eg. at the time I was hit by Menieres (the balance decease) - I was told by expert "You have to take Diuretics rest of your life.
I simply refused to accept that (after hearing how invalidating this could be) - and as I said - in the end - some non official supported medicine man like treatment actually made it possible for me to live 'a normal life' ever after until now.
So typically for me 'to loose a fortune' on a drug your supposed to take 'forever' rest of your life. A way of thinking that 'has newer been on my radar' - before one of my son's bought in to this stock before R-I in 2018 :)
-------------------
As a young man (pro in the military for eight years) - to much alcohol and partying - the 1970'ties was/is something to remember (dont remember a thing). But I think my Balance problem might be related to 'a not to healthy lifestyle for some 8 years' - before settling down with a family and children.
Those were the days Though :)
golf@ Following this board - and Amarin since autumn 2018 - I dont see this company 'Ever' being sold for neither $15 or even $20. It is simply not going to happen.
-----------------
There is Ever/Always talk about possible BO 'HERE' - I haven't heard one specific word from Amarin management about planning for BO.
At some point there were some very vague remarks from JT regarding 'sometime in the future - Maybe' - considering' - very very vague'.
------------------
A partnership for Europe - a more reasonable possibility. And if 'No BO' (which most Retail Investors would prefer - to get their life back) - something like Danish Novo Nordisk - would not be a bad partner - concurring European market FAST :)
Whal@ And Bye to You - Be Well !
I'm sorry to let you know -Trump will Win BIG - according to The Hill :)
https://thehill.com/opinion/campaign/522957-dont-believe-the-polls-trump-is-winning-bigly?rnd=1603816645
Just saw start of Dr. Zelenco video again (this guy is a true Hero to me) - and 2 people died (not 1 as i said) sorry for that misinformation.
-----------------------
Seeing video with Dr. Zelenco again almost beats coverage of the US election for me :)
Actually near end of the video there is some talk about Dr. Zelenco working with Bio company to develop an 'Inhaled' version of HCQ - that is in itself not that interesting.
What IS interesting is' - when Dr. Zelenco explains that Oral HCQ - the body absorbs about 2% of the active HCQ - and you need a weeks treatment to be sure infection stopped.
Inhaled HCQ - you need (from listening to video - I hear it as 1/50 of the Oral dose (but it could be 1/15) - and you only need 'One Inhaled Treatment to be protected'.
------------------
This lead to this 'vild thought' (being an absolut lay person in Bio knowledge). Would it maybe be possible to make a Vascepa Inhaled version (using 1/50 of the active EPA) - that would be an interesting perspective for price of' - and number of Sardines to support a patient per year :)
About 52 minutes into video the talk about 'Inhaled HCQ' in clinical trial starts.
WHAL@ Now it's Trumps fault that Vascepa - is not up front in Covid -treatment ?
----------------------
As much as I want success for (AMRN) Vascepa is not an antiviral drug. It would not have saved all the patients that Dr. Zelenco did - using simple logic:
"We haven't got time to wait for tests' - We will treat every person that comes in here 'suspected to be infected over 60 - with HCQ - Zink - Antibiotica) - and everyone else 'with Conditions - the same".
-------------
Out of Zelenco's 2200 patients - 800 were treated with HCQ combination - 1 died (4 on ventilators all recovered).
Results speaks for itself - and you criticize Trump for endorsing that ?
----------------------
Saving 'already infected people' - Vascepa is not the solution. A very effective Antiviral drug as HCQ is' (on of the best known - safest - and cheapest drugs used WW). Dr. Zelenco proved it to be 'The Solution' for treating Covid-19.
Big Pharma and Fauci - used the Trump hating MSM media - to 'kill information about HCQ' - as it did not meet their huge multi billion dollar dreams' of Vaccines and 'New Treatment's' !
The truth about US politics:
Whal@ You're a sick liberal person - accusing other posters of being Russian - just be cause they support President T.
Se your President a few hours ago - and veap:
Mateo@ Now your talking - and everything you say (at least to me) makes sense.
Have to start by apologizing for a little harsh reply earlier (applying you not listening to all the well ment answers) - reading your continued story I now understand 'you did just about every research possible - on your problem already.
------------------------
Telling about state of your body after the many years as a Judo fighter - it to me says 'your newebanes has been through so many blows' that no wonder you would get weird pain problems (lay mans explanation).
-------------------------
And your feet and toes is a mess you say. My imeade suggestion would bee that you try to contact an expert in Reflexology (called Zone-therapy in Danish). If you haven't tried that - you will be surprised how complex you nerve system is - eg. how the right pressure on a toe - can release actions in the complete body - that makes your urine almost black - from 'cleaning out' bad elements in blood and stomach.
As a young man (27) I suddenly was hit by a very unpleasant decease on the balance system - called Menieres. A condition in the inner ears - that make your balance system 'set out' periodcly - with no warning what so ever. You fall like a drunk sick chicken.
https://www.healthline.com/health/menieres-disease
At the time i vent to every 'regular' specialist - nothing helped before someone suggested to try Reflexology (basically pressing your toes and under your feet) - that cured the problem to an extent that i could keep my job (as an IT engineer (driving a car) on the road for NCR). Lost most of hearing on one year but have lived with that without major problems (other than can not locate direction of where noise is coming from - your ears is actually 'a radar' - eg. measuring the small delay to give direction of where the car is coming from )
What I remember I had some 8 - 10 treatments of about an hour from a very nice lady - who had learned this on some courses. But man can these small pressures on 'the right place - under your foot' - make every muscle your body react to an extent you wouldn't believe if you haven't tried it :)
Jasbg
BB@ Thanks for 'spelling' out what you mean - and found it - no problem:
-----------------------------------
But none of the links - goes anywhere. To me it seams like an 'IT' fenomena - Hikma staf controlling their Webpage - simply 'forgot to remove' some 'old' data regarding Vascepa. I could be wrong of cause :)
Meo@ We don't agree here. The 'science argument' absolutely stinks in this case (Remdesivir approved - a total joke - that is just about $$$$)
----------------------------
Why du you think Indian Government (world second largest population) Marts 23 2020 - ordered ALL front line personnel and Relatives to infected patients to Take HCQ - for gaining immunity (as has Lupus patients) - For Fun ?
How much has US Lib MSM media covered this - minus 100% (its been politics ever since T mentioned the treatment) Who cares about 'dying patients' as long as 'It damages T' - and we can 'keep pandemic alive until the billions' and billions' is to be made on Vaccines.
BB@ I cant find it either (tried in every combination possible):
---------------------------
Only document directly from Hikna 'still available (out there) is this PDF (big numbers the claim Vascepa sales)
https://www.hikma.com/media/2766/vascepa-press-release-positive-march-30-2020-720pmet-final.pdf
----------------------------
Just found one more Hikma document (PDF):
https://www.hikma.com/media/2777/trading-update-30-april-vfinal.pdf
Hikma announces strong start to 2020 and reiterates full year guidance
Maximising our flexible manufacturing capabilities to ensure patients get the medicines they
need during the COVID-19 crisis
Press Release
Hikma Confidential : For recipient only
London, 30 April 2020 – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group,
announces an update on trading in the year to date ahead of its Annual General Meeting which will be held today,
and provides an update on the actions it is taking to deliver critically needed medicines to patients during the COVID19 pandemic.
Hikma’s CEO, Siggi Olafsson said: “As the COVID-19 pandemic continues to impact people and communities around
the world, our top priority is the health and safety of our employees and the millions of patients across our markets
who count on our medicines.
As a company, we are leveraging our well-diversified product portfolio and high-quality, flexible manufacturing
facilities to respond to the needs of healthcare providers and their patients. We are prioritising the production and
delivery of the medicines in highest demand, while continuing to ensure we can supply our broad range of other
important medications. We have been proactively managing our inventory and stock levels and working closely with
our supplier networks. I am especially proud of our employees’ commitment during these unprecedented times,
enabling us to keep delivering high-quality medicines to the people that need them the most.
Hikma has made a strong start to the year despite the challenging market conditions that have arisen as a result of
COVID-19. This is a complex situation which we are continually monitoring, but we have confidence in the outlook
for the Group and we are pleased to reiterate our full year guidance for 2020.”
Injectables
Our global Injectables business is performing well. In the US and Europe, we are seeing an increase in demand
across our portfolio, driven in part by the COVID-19 outbreak. Our Injectables business in MENA is also seeing
strong demand, particularly for our biosimilar products.
Hikma’s Injectables product portfolio includes many of the products most in need by hospitals during the current
pandemic, including anaesthetics, analgesics, sedatives, neuromuscular blocking agents and anti-infectives. Our
commercial and operational teams are working closely with our customers and government agencies to ensure we
are able to maintain a consistent supply of these products. We are leveraging the flexibility of our global
manufacturing facilities and have been able to enhance productivity to meet the increased levels of demand.
We are pleased to announce that we have received US FDA approval for the first product from our new high
containment facility in Portugal, which can now begin to supply the US market. We are on track in terms of new
product launches and are making significant investments in our product pipeline.
Based on performance in the year to date, we are reiterating our guidance for global Injectables revenue growth in
the low to mid-single digits for 2020, driven by demand for our broad product portfolio across all our markets and
new product launches. We continue to expect core operating margin to be in the range of 35% to 37%. While we
are pleased with our performance in the year to date, our guidance reflects the uncertain operating environment
brought about by the COVID-19 pandemic.
Generics
Our Generics business has also had a good start to the year, building upon the strong performance of this segment
in 2019. We have seen good demand across our portfolio, particularly for our nasal sprays, and a better than
expected contribution from new products, including the first-to-market generic launch of everolimus tablets (a generic
version of Zortress®). We have also seen some additional demand related to COVID-19.
Hikma Confidential : For recipient only
We have made good progress in strengthening our R&D pipeline since the beginning of the year. At the end of
March, we successfully invalidated six US patents as asserted by Amarin for their Vascepa® capsules and continue
to work to bring this product to market. In addition, we continue to advance our nasal spray portfolio, leveraging the
strong technical capabilities at our Columbus facility to progress our naloxone nasal spray submission.
For the full year, we continue to expect Generics revenue in the range of $700 million to $750 million. Our guidance
assumes that we will launch generic Advair Diskus® in the second half of the year and we have included revenue of
$20 million to $40 million from generic Advair Diskus® in this range. We expect our core operating margin for the
Generics business to be between 16% and 18% or, including the launch of generic Advair Diskus®, around 20%.
Branded
Our Branded business is also performing well. We have seen good demand across most of our markets, and
particularly in our Tier 1 markets of Egypt and Saudi Arabia as well as in Algeria, where we have seen a strong
recovery reflecting a more benign market environment. In some of our markets we have also seen an increase in
demand related to COVID-19.
While the pandemic has impacted our promotional activities, our teams have responded quickly to the challenges
posed by distancing restrictions and have found new ways to reach health care providers across the region, including
detailing doctors online and hosting virtual conferences. Some of our manufacturing facilities across the region have
experienced slight disruptions but our teams have managed this well and production across our facilities is
normalising.
We remain confident in the outlook for the Branded business and continue to expect revenue growth in constant
currency to be in the mid-single digits for the full year in 2020.
Strong balance sheet and final dividend
Subject to approval at today’s Annual General Meeting, we will be paying a final dividend of 30 cents per share
(approximately 23 pence per share) bringing the total dividend for the full year to 44 cents per share (approximately
34 pence per share), an increase of 16% on 2018. In the current environment, this demonstrates the strength of our
balance sheet and our confidence in our ability to maintain strong cash generation and low leverage.
We will announce our interim results for the six months to 30 June 2020 on 7 August 2020.
-- ENDS --
Kine@ You totally ignore Dr. Zelenco - and 'fabricate something' about HCQ.
--------------------
Don't you understand: IT HAS BEEN USED IN REST OF THE WORLD - just not parts of USA and Europe (for political reasons). Of course it Works.
Everyone (already start of marts) knew that it was/is all about getting the Antivirus early (before day 6) - after that 'it's a different story'.
You obviously did not see the video with Dr. Zelenco at all - or you would understand 'why HCQ' was/is the solution for treating Covid-19 WW.